We then examined the role of SGF29 in different human cancer cell lines and observed that sgSGF29 exhibited a selective impact on the MV4-11 and MOLM13 (leukemia) over the NCI-H661 (lung carcinoma), U251 (glioblastoma), and HepG2 (hepatocellular carcinoma) cells (Fig. 1H and fig. The gene discussed is SGF29; the disease is hepatocellular carcinoma.